Lifestance Health Group Stock Alpha and Beta Analysis
| LFST Stock | USD 7.13 0.01 0.14% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Lifestance Health Group. It also helps investors analyze the systematic and unsystematic risks associated with investing in Lifestance Health over a specified time horizon. Remember, high Lifestance Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Lifestance Health's market risk premium analysis include:
Beta 0.5 | Alpha 0.49 | Risk 4.19 | Sharpe Ratio 0.12 | Expected Return 0.5 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Lifestance | Build AI portfolio with Lifestance Stock |
Lifestance Health Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Lifestance Health market risk premium is the additional return an investor will receive from holding Lifestance Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Lifestance Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Lifestance Health's performance over market.| α | 0.49 | β | 0.50 |
Lifestance Health expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lifestance Health's Buy-and-hold return. Our buy-and-hold chart shows how Lifestance Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Lifestance Health Market Price Analysis
Market price analysis indicators help investors to evaluate how Lifestance Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lifestance Health shares will generate the highest return on investment. By understating and applying Lifestance Health stock market price indicators, traders can identify Lifestance Health position entry and exit signals to maximize returns.
Lifestance Health Return and Market Media
The median price of Lifestance Health for the period between Wed, Oct 1, 2025 and Tue, Dec 30, 2025 is 6.25 with a coefficient of variation of 12.59. The daily time series for the period is distributed with a sample standard deviation of 0.75, arithmetic mean of 5.96, and mean deviation of 0.69. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 61508 shares by Ryan Pardo of Lifestance Health at 5.4 subject to Rule 16b-3 | 10/17/2025 |
2 | LifeStance Health Group, Inc. Stock Analysis Exploring a 61.5 percent Upside Potential in the Mental Health Sector - DirectorsTalk Interviews | 10/21/2025 |
3 | Does Calm Health Partnership Signal a New Growth Path for LifeStance Health Group | 11/06/2025 |
4 | Disposition of 10623 shares by Lisa Miller of Lifestance Health at 6.43 subject to Rule 16b-3 | 11/10/2025 |
5 | Is LifeStance Health Group Inc. stock a good choice for value investors - Options Play Long-Term Capital Growth Ideas - newser.com | 11/14/2025 |
6 | Wall Street Analysts Think LifeStance Health Could Surge 30.49 percent Read This Before Placing a Bet | 11/28/2025 |
7 | Should I hold or sell LifeStance Health Group Inc. stock in 2025 - July 2025 Snapshot Consistent Income Trade Recommendations - Newser | 12/02/2025 |
8 | LifeStance Health Group Now Covered by Analysts at Barclays - MarketBeat | 12/09/2025 |
9 | BTIG Research Boosts LifeStance Health Group Price Target to 10.00 | 12/12/2025 |
10 | Disposition of 6186 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16b-3 | 12/15/2025 |
11 | LifeStance Health Group, Inc. Receives 9.00 Average PT from Brokerages | 12/16/2025 |
12 | Disposition of 50000 shares by Ann Varanakis of Lifestance Health at 6.9 subject to Rule 16b-3 | 12/17/2025 |
13 | Disposition of 3221 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16b-3 | 12/18/2025 |
14 | Disposition of 850 shares by Bessler Robert of Lifestance Health at 7.04 subject to Rule 16b-3 | 12/22/2025 |
15 | Disposition of 2450 shares by Bessler Robert of Lifestance Health at 7.01 subject to Rule 16b-3 | 12/26/2025 |
About Lifestance Health Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Lifestance or other stocks. Alpha measures the amount that position in Lifestance Health has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Payables Turnover | 117.17 | 123.03 | Days Of Inventory On Hand | 26.84 | 23.86 |
Lifestance Health Upcoming Company Events
As portrayed in its financial statements, the presentation of Lifestance Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lifestance Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Lifestance Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Lifestance Health. Please utilize our Beneish M Score to check the likelihood of Lifestance Health's management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Lifestance Health
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Lifestance Stock Analysis
When running Lifestance Health's price analysis, check to measure Lifestance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifestance Health is operating at the current time. Most of Lifestance Health's value examination focuses on studying past and present price action to predict the probability of Lifestance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifestance Health's price. Additionally, you may evaluate how the addition of Lifestance Health to your portfolios can decrease your overall portfolio volatility.